Found: 4
Select item for more details and to access through your institution.
Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2852, doi. 10.3390/cancers16162852
- By:
- Publication type:
- Article
Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01738-x
- By:
- Publication type:
- Article
Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT Signaling.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 12, p. 1873, doi. 10.3390/cells11121873
- By:
- Publication type:
- Article
Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 10, p. 1357, doi. 10.3390/biom10101357
- By:
- Publication type:
- Article